Kymera Therapeutics 주식 가격. KYMR - 주식 시세, 차트, 과거 거래, 주식 채팅, 재무.

개인 투자자를 위한 전문가급 도구.

프리미엄

가격

40.45

매수가

38.40

매도가

47.63

거래량

354,964

39.005 일간 변동폭 41.20

29.33 52주 범위 53.27

market_cap

2.62B

전일 종가

39.40

개장가

39.79

최근 거래 시간

42.05

마지막 거래 시간

재정 규모

US$ 14,221,981

VWAP

40.066

평균 볼륨(3m)

488,449

발행 주식

64,765,274

배당수익률

주가수익률

-17.88

주당순이익(EPS)

-2.27

매출

78.59M

순이익

-146.96M

Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causin... Kymera Therapeutics Inc is a biotechnology company pioneering a transformative new approach to treating previously untreatable diseases. The company is advancing the field of targeted protein degradation, accessing the body's innate protein recycling machinery to degrade dysregulated, disease-causing proteins. Kymera's Pegasus targeted protein degradation platform harnesses the body's natural protein recycling machinery to degrade disease-causing proteins, with a focus on un-drugged nodes in validated pathways currently inaccessible with conventional therapeutics. It is accelerating drug discovery with an unmatched ability to target and degrade intractable proteins and advance new treatment options for patients. 더 보기

섹터

Biological Pds,ex Diagnstics

산업

Biological Pds,ex Diagnstics

웹사이트

www.kymeratx.com

본부

Wilmington, Delaware, USA

설립됨

Kymera Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the 나스닥 with ticker KYMR. The last closing price for Kymera Therapeutics was US$39.40. Over the last year, Kymera Therapeutics shares have traded in a share price range of US$ 29.33 to US$ 53.27.

Kymera Therapeutics currently has 64,765,274 shares in issue. The market capitalisation of Kymera Therapeutics is US$2.55 billion. Kymera Therapeutics has a price to earnings ratio (PE ratio) of -17.88.

Kymera Therapeutics to Participate in Upcoming February Investor Conferences

WATERTOWN, Mass., Jan. 30, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader...

Form 8-K - Current report

Kymera Therapeutics Outlines Key 2025 Objectives and Strategy to Advance Industry Leading Portfolio of Oral Immunology Programs

KT-621 (STAT6) Phase 1 healthy volunteer trial ongoing, with data expected in 2Q25 Kymera plans to initiate a KT-621 Phase 1b trial in atopic dermatitis (AD) patients in 2Q25 with data in 4Q25...

기간	변동	변동 %	시가	고가	저가	평균 일일 거래량	VWAP
1	-3.51	-7.98453139217	43.96	45.31	38.96	544772	42.08734369	CS
4	-0.45	-1.10024449878	40.9	45.31	35.57	528802	41.05976242	CS
12	-9.07	-18.3158319871	49.52	53.23	35.57	488449	43.0061407	CS
26	-3.6	-8.17253121453	44.05	53.27	35.57	450544	44.84400272	CS
52	8.31	25.8556316117	32.14	53.27	29.33	533386	40.64602469	CS
156	2.2	5.75163398693	38.25	53.27	9.6	604548	29.9505604	CS
260	7.53	22.8736330498	32.92	91.92	9.6	513232	34.33410134	CS

KYMR - Frequently Asked Questions (FAQ)

What is the current Kymera Therapeutics share price?

The current share price of Kymera Therapeutics is US$ 40.45

How many Kymera Therapeutics shares are in issue?

Kymera Therapeutics has 64,765,274 shares in issue

What is the market cap of Kymera Therapeutics?

The market capitalisation of Kymera Therapeutics is USD 2.55B

What is the 1 year trading range for Kymera Therapeutics share price?

Kymera Therapeutics has traded in the range of US$ 29.33 to US$ 53.27 during the past year

What is the PE ratio of Kymera Therapeutics?

The price to earnings ratio of Kymera Therapeutics is -17.88

What is the cash to sales ratio of Kymera Therapeutics?

The cash to sales ratio of Kymera Therapeutics is 33.44

What is the reporting currency for Kymera Therapeutics?

Kymera Therapeutics reports financial results in USD

What is the latest annual turnover for Kymera Therapeutics?

The latest annual turnover of Kymera Therapeutics is USD 78.59M

What is the latest annual profit for Kymera Therapeutics?

The latest annual profit of Kymera Therapeutics is USD -146.96M

What is the registered address of Kymera Therapeutics?

The registered address for Kymera Therapeutics is CORPORATION TRUST CENTER, 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Kymera Therapeutics website address?

The website address for Kymera Therapeutics is www.kymeratx.com

Which industry sector does Kymera Therapeutics operate in?

Kymera Therapeutics operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

가장 활성
% 상승자
% 패자

기호	가격	볼륨
FOXXFoxx Development Holdings Inc	US$ 6.355 (119.90%)	33.52M
BHILBenson Hill Inc	US$ 3.925 (118.06%)	13.52M
TECXTectonic Therapeutic Inc	US$ 55.18 (114.54%)	5.46M
AMODAlpha Modus Holdings Inc	US$ 3.2299 (109.73%)	125.47M
DOMHDominari Holdings Inc	US$ 3.61 (59.03%)	4.24M
CLEUChina Liberal Education Holdings Ltd	US$ 0.149 (-98.08%)	311.38M
CRGXCARGO Therapeutics Inc	US$ 3.39 (-74.30%)	21.21M
TDTHTrident Digital Tech Holdings Ltd	US$ 1.0159 (-58.87%)	2.46M
EVTVEnvirotech Vehicles Inc	US$ 0.338202 (-49.30%)	4.78M
IRWDIronwood Pharmaceuticals Inc	US$ 2.29 (-38.44%)	10.53M
NVDANVIDIA Corporation	US$ 124.65 (0.77%)	392.11M
CLEUChina Liberal Education Holdings Ltd	US$ 0.149 (-98.08%)	311.38M
MGOLMGO Global Inc	US$ 0.1199 (17.90%)	166.88M
SPGCSacks Parente Golf Inc	US$ 0.93 (57.63%)	129.08M
RIMEAlgorhythm Holdings Inc	US$ 0.02465 (-5.19%)	126.09M